Clinical trials of GLP-1 obesity drugs show impressive average weight loss, but responses vary from person to person. Genetics may help explain why. A study from 23andMe links genetic variants to weight loss and side effects. My latest story for @nature.com www.nature.com/articles/d41...
www.nature.com
Study of almost 28,000 people also identifies genetic variants that raise the risk of gastrointestinal side effects from GLP-1 medications.
